Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juniper tar is a dark brown or yellowish viscous liquid obtained by the destructive distillation of the branches and wood of Juniperus oxycedrus. It contains etheric oils, triterpenes and phenols. Traditionally used in folk medicine and topical preparations for its antipruritic properties in chronic dermatologic disorders such as atopic dermatitis and seborrhea. It has also been used externally for superficial wounds and burns[1][3][5]. Juniper tar is considered toxic if ingested or applied inappropriately; poisoning can result in fever, hypotension, renal failure and hepatotoxicity[4]. Its mechanism of action is not well defined but it acts as a topical antipruritic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on juniper tar.